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1. Introduction 
Cytochromes P-450 comprise a ubiquitous class of 
hemoproteins, members of which are involved in 
binding and activation of molecular oxygen and sub- 
sequent mixed-function oxidation of a wide variety of 
substrates [ 1,2]. These enzymes were first dis- 
tinguished by their unusual optical absorption spectrum 
when in the ferrous oxidation state with carbon 
monoxide bound as a heme ligand [3,4]. Whereas, 
carbon monoxide derivatives of heme proteins such as 
hemoglobin and myoglobin exhibit Soret absorptions 
near 420 nm, carbon monoxy cytochromes P-450 
absorb near 450 nm. previous e.p.r. studies have 
demonstrated that sulfur, presumably from cysteine, is 
a necessary axial ligand in all low-spin ferric 
cytochromes P-450 [S-8] but evidence that this 
ligand also occurs in the ferrous state has been non- 
existent. Since oxygen binding to the ferrous proteins 
will be affected by the iron ligand it displaces and/or 
the ligand remaining which is truns to it, the identitica- 
tion of the unusual state of heme ligation found in 
ferrous cytochrome P-450 is essential to our under- 
standing of enzyme function. 
Recently, we have been able to reproduce the 
atypical optical spectrum of carbon monoxy cyto- 
chrome P-450 using models composed of mononuclear 
ferrous heme, CO and mercaptide anion (RS-) [9,10]. 
These results, subsequently confirmed in different 
laboratories [ 11,121, strongly suggest he requirement 
for mercaptide anion as a ferrous heme ligand tram 
to CO in order to produce the unusual optical 
property that distinguishes cytochrome P-450 from 
other hemoproteins. 
364 
Not only can ferrous cytochrome P-450 bind to 
CO, but it is also capable of binding other exogenous 
ligands as well. One of these, nitric oxide, binds to 
cytochromes P-450 obtained from both liver micro- 
somal and bacterial sources [ 131. In a similar fashion 
that CO elicits an unusual Soret absorption from 
ferrous cytochrome P-450, NO does as well. Here, 
the Soret absorption is at 437 nm as compared to 
the usual absorption of 420 nm observed for 
nitrosyl myoglobin. 
In this present communication, we describe the 
optical properties of a model compound for nitrosyl 
cytochrome P-450. We demonstrate that the require- 
ment for.mercaptide anion as a necessary heme 
ligand is a property of NO as well as CO ligation in 
these heme proteins. 
2. Materials and methods 
Dimethylsulfoxide (DMSO) (Burdick and Jackson, 
Inc., Muskegon, Michigan), deoxygenated by equilibra- 
tion with argon, was saturated with sodium methyl 
mercaptide (0.30 M) followed by the anaerobic addi- 
tion of dibenzo- 18-crown-6 polyether (0.15 M) in 
order to enhance the activity of the mercaptide anion 
in the solvent [ 111. Reagent grade crown ether was 
found to contain colored impurities which were 
removed by 2 X recrystallization from chloroform. 
prior to adding nitric oxide, the solution of sodium 
methyl mercaptide and crown ether was mixed in a 
Thunberg optical cell with hemin chloride dissolved 
in DMSO (6- 16 PM) either under argon or CO. 
Nitric oxide was scrubbed first through a concentrated 
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solution of NaOH to remove higher oxides of nitrogen 
which causes precipitation and destruction of heme, 
followed by a column of NaOH pellets in order to 
remove water vapor. Hemin chloride was treated 
briefly before use with dry HCl gas in CHCls in order 
to cleave any /.L-0x0 contaminants. In some cases the 
methyl mercaptide was replaced by an alkyl mercaptan 
(R = CHs-,CHs(CH&-,0HCHzCH2-, any of which 
yield similar esults) of equivalent concentration. 
3. Results 
The typical absorption spectrum of heme CO is 
shown in fig. 1 (curve a) resulting from mixing an 
alkyl mercaptan with ferric hemin chloride in DMSO 
under a CO atmosphere. This species exhibits absorp- 
tion maxima t 332 nm (e,M = 40), 414 nm (emM = 
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200), 535 nm (emM = 13) and 567 nm (e,M = 16). 
As previously reported [9] the formation of this 
species is independent of the presence of mercaptan 
except as a source of reducing equivalents for the 
ferric heme. If this sample is now flushed with argon 
for a few minutes the spectral features of ferrous 
heme (figl, curve b) are seen at 424 nm (emM = 205), 
525 nm (em& = 12) and 555 nm (emM = 15). The same 
spectrum is observed in the absence of mercaptan if 
dithionite is used as a reductant. The introduction of 
nitric oxide at this point generates a heme NO species 
(fig. 1, curve c) with absorption maxima t 402 nm . 
(emM = 88) and 556 nm (emM = 11). Now adding 
pyridine shifts the Soret to 420 nm and the visible 
spectrum is that of a characteristic nitrosyl heme 
complex, similar to that seen for nitrosyl myoglobin 
(table 1). 
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Fig.1. Optical absorption spectra of heme compounds prepared in the presence of mercaptoethanol. In (a) hemin chloride in 
dimethylsulfoxide was reacted with CO, in (b) CO was purged from the solution with argon, while in (c) NO was added afterwards. 
The concentration of heme (6.60 X lob6 M) was the same in all three spectra. 
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Fig.2. Optical absorption spectra of heme compounds prepared in the presence of sodium methyl mercaptide and dibenzo-18-crown- 
6-ether. In (a) hemin chloride in dimethylsulfoxide was reacted with CO, in (b) CO was purged from the solution with argon, and in 
(c) NO was added afterwards. The concentration of heme in (a) and (b) was 1.61 X 10e5 M and was 1.22 X lo-” M in (~1. 
ferric hemin chloride, sodium methyl mercaptide and 
crown ether in DMSO under CO is shown in fig.2 
(curve a). This h~perporphyrin spectrum [ 141 is 
characteristic of the CO adduct of ferrous cytochrome 
P-450. Absorption features are seen at 380 nm 
(e mM = 60) 460 nm (emM = 73) and 555 nm (emM = 12). 
The absorptions at 380 and 460 nm can be shifted 
by about l0 nm to higher energy (i.e., 370 (emM = 70) 
and 450 nm (emM = 85), respectively) remniscent of 
carbon monoxy cytochrome P-450, if a 1: 1 DMSO- 
ethanol solvent mixture replaces the DMSO [9]. 
However, ethanolysis of sodium methyl mercaptide 
takes place in this solvent mixture and is therefore 
not routinely used*. If the carbon monoxide is 
*As ethanolysis converts the sodium methyl mercaptide to 
methyl mercaptan, the 450 nm-absorbing species decreases 
and the 414 nm-absorbing species appears. 
removed from the model compound in DMSO by 
gassing with argon, a normal-porphyrin spectrum is 
seen (fig.2, curve b), with A,, at 410 nm (emM = 80) 
and 550 nm (fmM = 13) which differs markedly from 
the compound prepared where a thiol is used instead 
of a mercaptide (fig. 1). Both of these ferrous heme 
species are stable and completely interconvertible to 
their respective CO complexes by cycling back and 
forth with argon and CO. When nitric oxide is added 
to the ferrous heme mercaptide complex in the 
presence of CO, precipitation takes place obscuring 
the optical spectrum. If, however, aliquots of NO are 
added after the removal of CO with argon, a new 
hyperporphyrin spectral species is formed (fig.2, 
curve c) which is identical to that seen for nitrosyl 
cytochrome P-450 [ 13 3, with absorption maxima at 
370 nm (emM = 84), 437 nm (emM = 92) and 557 nm 
(e&l = 14) (table 1). 
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Table 1 
Soret and visible absorption maxima of nitrosyl 
heme complexes 
NO+ 
Heme 
Heme + alkyl mercaptan 
Heme + sodium methyl mercaptide 
Heme + pyridine 
Cytochrome P-450cama 
Sperm whale myoglobinb 
402,556 
402,556 
437,557 
420,545,576 
438,558 
420,543,577 
aAfter [12]. 
bPrepared by the NO displacement of CO in sperm whale carbo 
myoglobin (Seravac). 
4. Discussion 
The intensive investigations by our group [9,10] 
and others [ 11,121 regarding the spectral properties 
of heme-mercaptide complexes strongly imply that 
mercaptide anion is ligated to heme in CO complexes 
of cytochromes P-450. The ability of mercaptide anion 
to generate these unique cytochrome P-450 spectra 
is now firmly based on theoretical grounds which has 
provided a molecular orbital explanation for these 
types of hyperporphyrin spectra [ 141. From the 
spectral similarities of the model compound prepared 
from heme, mercaptide anion and NO compared with 
the nitrosyl derivative of cytochrome P-450,,, (table I), 
we conclude that the same mercaptide ligation occurs 
for the NO complexes as well. 
Based on the spectral differences observed for 
ferrous heme prepared both in the presence and 
absence of mercaptide (figs.1 and 2) it is suggested 
that mercaptide anion binds to heme even in the 
absence of CO or NO. It is unlikely that undissociated 
thiol binds to heme [ 151 as its absence has little 
effect on the optical spectrum of ferrous heme as 
well as the CO- and NO-ligated forms. 
Recently, Chang and Dolphin [ 121 have synthesized 
and oxygenated mercaptide heme complex which also 
displays a hyperporphyrin absorption spectrum. In 
this case, the Soret absorption is at 428 nm ( as com- 
pared to oxygenated complexes of hemoglobin and 
myoglobin which absorb near 418 nm) and also 
shows a strong absorption in the ultraviolet. Curiously, 
the oxygenated complex of cytochrome P-450, 
[ 161 exhibits a normal porphyrin spectrum with a 
weak absorption in the ultraviolet, a Soret absorption 
centered at 418 nm and a visible absorption very 
similar to that for oxymyoglobin, oxyhemoglobin or 
a complex of imidazole, ferrous heme and oxygen 
[ 171. Whereas NO or CO binding to cytochrome P-450 
can be demonstrated either in the presence or absence 
of substrate, oxygen binding can only be demonstrated 
when substrate is present [18,19]. It is suggested, 
therefore, that in oxy cytochrome P-450, mercaptide 
is no longer bound to heme, being displaced by the 
oxygen molecule [20]. The mechanism of control 
of binding neutral diatomic molecules has been 
speculated upon [21] for hemoglobin, but this 
differentiation of 02- as compared to NO- and CO- 
ligation is unique in hemoprotein chemistry and will 
undoubtedly provide insight into the activation of 
molecular oxygen as related to drug metabolism. 
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